by Administrateur Biofortis | Feb 15, 2018 | Food, Health, Nutrition
The new regulation 2017/745 on medical devices was adopted on spring 2017, replacing the existing directives. A transitional period is ongoing to May 2020, date of the implementation. According to the European Commission, this new text “establishes a modernised and...
by Administrateur Biofortis | Feb 1, 2018 | Microbiome
FROM RESEARCH TO MICROBIOME INSIGHTS These last years, murine genetics manipulations have lead to development of multiple murine models (germ-free, gnotobiotic…). Consequently, microbiome researchers now have tools to study links between microbiota and disease that...
by Administrateur Biofortis | Dec 28, 2017 | Food, Microbiome, Non classé, Nutrition
In satiety regulation, the balance between anorexigenic (PP, CCK, PYY3-36, incretins, leptin, OXM) and orexigenic (ghrelin, insl5, adiponectin) signals is determinant. A special attention should be attributed to incretins (GLP-1, GIP). Incretins are key gut-derived...
by Administrateur Biofortis | Nov 21, 2017 | Microbiome
Biofortis’ scientist experts were attending the 5th World Congress on Targeting Microbiota organised by the International Society of Microbiota. During this two-day conference in Berlin, a lot of oral and poster communications were presented covering many hot topics:...
by Administrateur Biofortis | Nov 10, 2017 | Microbiome
Hervé Affagard CEO – Co-Founder of MaaT Pharma Engineer, Executive MBA, Certificate “Exploring your Microbiome” 1/ What is your professional background? I lead the MaaT Pharma project since its inception phase in December 2013. Previously I worked as an entrepreneur...
